CY-303

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCY-303
Drug Alias Namecontact dermatitis therapy (Cytogenix)CY-302CY-303
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsInflammationDermatitis, Contact
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytoGenix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytoGenix Inc
Active IndicationsN/A
Inactive IndicationsInflammationDermatitis, Contact

Other Information

ATC CodeN/A
Related LinksN/A